These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 18550411)
1. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Lafontan M; Girard J Diabetes Metab; 2008 Sep; 34(4 Pt 1):317-27. PubMed ID: 18550411 [TBL] [Abstract][Full Text] [Related]
2. Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism. Girard J; Lafontan M Diabetes Metab; 2008 Nov; 34(5):439-45. PubMed ID: 18562233 [TBL] [Abstract][Full Text] [Related]
3. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects. Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190 [TBL] [Abstract][Full Text] [Related]
4. Higher free fatty acid uptake in visceral than in abdominal subcutaneous fat tissue in men. Hannukainen JC; Kalliokoski KK; Borra RJ; Viljanen AP; Janatuinen T; Kujala UM; Kaprio J; Heinonen OJ; Viljanen T; Haaparanta M; Iozzo P; Parkkola R; Nuutila P Obesity (Silver Spring); 2010 Feb; 18(2):261-5. PubMed ID: 19696757 [TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein expression is upregulated in adipocytes in obesity. Lee YH; Tharp WG; Maple RL; Nair S; Permana PA; Pratley RE Obesity (Silver Spring); 2008 Jul; 16(7):1493-500. PubMed ID: 18483477 [TBL] [Abstract][Full Text] [Related]
6. Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage. Raz I; Eldor R; Cernea S; Shafrir E Diabetes Metab Res Rev; 2005; 21(1):3-14. PubMed ID: 15386813 [TBL] [Abstract][Full Text] [Related]
7. Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women. Drolet R; Bélanger C; Fortier M; Huot C; Mailloux J; Légaré D; Tchernof A Obesity (Silver Spring); 2009 Mar; 17(3):424-30. PubMed ID: 19219061 [TBL] [Abstract][Full Text] [Related]
8. Subcutaneous and visceral adipose tissue: structural and functional differences. Ibrahim MM Obes Rev; 2010 Jan; 11(1):11-8. PubMed ID: 19656312 [TBL] [Abstract][Full Text] [Related]
10. Adipotoxicity and the insulin resistance syndrome. Anderwald C; Roden M Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024 [TBL] [Abstract][Full Text] [Related]
11. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Bays HE; González-Campoy JM; Bray GA; Kitabchi AE; Bergman DA; Schorr AB; Rodbard HW; Henry RR Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):343-68. PubMed ID: 18327995 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Dahlman I; Forsgren M; Sjögren A; Nordström EA; Kaaman M; Näslund E; Attersand A; Arner P Diabetes; 2006 Jun; 55(6):1792-9. PubMed ID: 16731844 [TBL] [Abstract][Full Text] [Related]
14. Associations between circulating free fatty acids, visceral adipose tissue accumulation, and insulin sensitivity in postmenopausal women. Lapointe A; Piché ME; Weisnagel SJ; Bergeron J; Lemieux S Metabolism; 2009 Feb; 58(2):180-5. PubMed ID: 19154950 [TBL] [Abstract][Full Text] [Related]
15. Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial. Punthakee Z; Alméras N; Després JP; Dagenais GR; Anand SS; Hunt DL; Sharma AM; Jung H; Yusuf S; Gerstein HC Diabet Med; 2014 Sep; 31(9):1086-92. PubMed ID: 24890138 [TBL] [Abstract][Full Text] [Related]
16. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555 [TBL] [Abstract][Full Text] [Related]
17. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Jensen MD Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():20S-24S. PubMed ID: 16642959 [TBL] [Abstract][Full Text] [Related]
18. [Relation between insulin resistance and amount of visceral adipose tissue]. Bajzová M; Kováciková M; Vítková M; Polák J; Klimcáková E; Srp A; Vedral T; Mikulásek L; Srámková SP; Stich V; Hejnová J Cas Lek Cesk; 2008; 147(7):376-80. PubMed ID: 18678096 [TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of insulin resistance in IGT]. Asakawa H; Tokunaga K Nihon Rinsho; 1997 Nov; 55 Suppl():822-6. PubMed ID: 9434571 [No Abstract] [Full Text] [Related]
20. Expression of the transcription factor 7-like 2 gene (TCF7L2) in human adipocytes is down regulated by insulin. Ahlzén M; Johansson LE; Cervin C; Tornqvist H; Groop L; Ridderstråle M Biochem Biophys Res Commun; 2008 May; 370(1):49-52. PubMed ID: 18342627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]